IRCT20200727048217N1
Recruiting
Phase 3
Prophylaxis and treatment of COVID-19 using a nasal spray containing 3% dimethyl sulfoxide (DMSO) and 20% ethanol solution
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahroud University of Medical Sciences
- Enrollment
- 610
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •COVID\-19 Patients
- •Close contact with COVID\-19 Patinets
- •No current and previous infection with COVID\-19 (for the preventive phase)
Exclusion Criteria
- •immigrant patients
- •pregnant patients
- •Anxiety and obsessive\-compulsive disorder
- •Protocol noncompliance
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Prevention and treatment for covid-19 associated severe pneumonia in The Gambia: a randomized clinical trial (PaTS-COVID) COVID-19PACTR202101544570971Medical Research Council Unit The Gambia at LSHTM1,200
Not yet recruiting
Not Applicable
Ozone Therapy for Covid 19 patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/07/026671Bisleri charitable trust
Not yet recruiting
Not Applicable
se of Hemopurifier Device For The Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans.Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2021/10/037591Aethlon Medical Inc
Recruiting
Not Applicable
Treatment of Sars-CoV2 infections (Covid-19) with valsartan vs placebo, a three-armed randomized, partly blinded trialCovid-19DRKS00021732Klinikum St. Georg gGmbH300
Not yet recruiting
Phase 2
se of Steroid inhalers in COVID.CTRI/2021/05/033817YOU BREATHE WE CARE